{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:02:06Z","timestamp":1788825726490,"version":"build-2803163510"},"reference-count":64,"publisher":"BMJ","issue":"10","license":[{"start":{"date-parts":[[2023,10,5]],"date-time":"2023-10-05T00:00:00Z","timestamp":1696464000000},"content-version":"unspecified","delay-in-days":4,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013891","name":"Parkinson Vereniging","doi-asserted-by":"publisher","award":["2019-R03"],"award-info":[{"award-number":["2019-R03"]}],"id":[{"id":"10.13039\/501100013891","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2023,8,30]]},"published-print":{"date-parts":[[2023,10]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Experimental studies suggest a role of gut microbiota in the pathophysiology of Parkinson\u2019s disease (PD) via the gut\u2013brain axis. The gut microbiota can also influence the metabolism of levodopa, which is the mainstay of treatment of PD. Therefore, modifying the gut microbiota by faecal microbiota transplantation (FMT) could be a supportive treatment strategy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>We have developed a study protocol for a single-centre, prospective, self-controlled, interventional, safety and feasibility donor-FMT pilot study with randomisation and double-blinded allocation of donor faeces. The primary objectives are feasibility and safety of FMT in patients with PD. Secondary objectives include exploring whether FMT leads to alterations in motor complications (fluctuations and dyskinesias) and PD motor and non-motor symptoms (including constipation), determining alterations in gut microbiota composition, assessing donor\u2013recipient microbiota similarities and their association with PD symptoms and motor complications, evaluating the ease of the study protocol and examining FMT-related adverse events in patients with PD. The study population will consist of 16 patients with idiopathic PD that use levodopa and experience motor complications. They will receive FMT with faeces from one of two selected healthy human donors. FMT will be administered via a gastroscope into the duodenum, after treatment with oral vancomycin, bowel lavage and domperidone. There will be seven follow-up moments during 12 months.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>This study was approved by the Medical Ethical Committee Leiden Den Haag Delft (ref. P20.087). Study results will be disseminated through publication in peer-reviewed journals and international conferences.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>International Clinical Trial Registry Platform: NL9438.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2023-071766","type":"journal-article","created":{"date-parts":[[2023,10,5]],"date-time":"2023-10-05T12:00:40Z","timestamp":1696507240000},"page":"e071766","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":19,"title":["Safety and feasibility of faecal microbiota transplantation for patients with Parkinson\u2019s disease: a protocol for a self-controlled interventional donor-FMT pilot study"],"prefix":"10.1136","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9259-4920","authenticated-orcid":false,"given":"Karuna EW","family":"Vendrik","sequence":"first","affiliation":[{"name":"Department of Medical Microbiology, Centre for Infectious Diseases, Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4437-6259","authenticated-orcid":false,"given":"Vlada O","family":"Chernova","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology, Centre for Infectious Diseases, Leiden University Medical Center, Leiden, The Netherlands"},{"name":"Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ed J","family":"Kuijper","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology, Centre for Infectious Diseases, Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth M","family":"Terveer","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology, Centre for Infectious Diseases, Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacobus J","family":"van Hilten","sequence":"additional","affiliation":[{"name":"Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0312-184X","authenticated-orcid":false,"given":"Maria Fiorella","family":"Contarino","sequence":"additional","affiliation":[{"name":"Department of Neurology, Leiden University Medical Center, Leiden, The Netherlands"},{"name":"Department of Neurology, Haga Teaching hospital, The Hague, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2023,10,5]]},"reference":[{"key":"2025121601510684000_13.10.e071766.1","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.54.1.30"},{"key":"2025121601510684000_13.10.e071766.2","doi-asserted-by":"publisher","DOI":"10.1038\/42166"},{"key":"2025121601510684000_13.10.e071766.3","doi-asserted-by":"publisher","DOI":"10.1002\/mds.24996"},{"key":"2025121601510684000_13.10.e071766.4","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.2008.02056.x"},{"key":"2025121601510684000_13.10.e071766.5","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10030493","article-title":"Gastrointestinal dysfunction in parkinson's disease","volume":"10","author":"Skj\u00e6rb\u00e6k","year":"2021","journal-title":"J Clin Med"},{"key":"2025121601510684000_13.10.e071766.6","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s00702-002-0808-2","article-title":"Idiopathic parkinson\u2019s disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen","volume":"110","author":"Braak","year":"2003","journal-title":"J Neural Transm (Vienna)"},{"key":"2025121601510684000_13.10.e071766.7","doi-asserted-by":"publisher","DOI":"10.1002\/mds.25020"},{"key":"2025121601510684000_13.10.e071766.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2012.04.009"},{"key":"2025121601510684000_13.10.e071766.9","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2982.2012.01974.x"},{"key":"2025121601510684000_13.10.e071766.10","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddq038"},{"key":"2025121601510684000_13.10.e071766.11","doi-asserted-by":"publisher","DOI":"10.1002\/ana.24648"},{"key":"2025121601510684000_13.10.e071766.12","doi-asserted-by":"publisher","DOI":"10.1016\/0014-5793(91)80657-O"},{"key":"2025121601510684000_13.10.e071766.13","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-014-1343-6"},{"key":"2025121601510684000_13.10.e071766.14","doi-asserted-by":"publisher","DOI":"10.1002\/emmm.201302475"},{"key":"2025121601510684000_13.10.e071766.15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0008762","article-title":"Progression of parkinson\u2019s disease pathology is reproduced by intragastric administration of rotenone in mice","volume":"5","author":"Pan-Montojo","year":"2010","journal-title":"PLoS One"},{"key":"2025121601510684000_13.10.e071766.16","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0509567103"},{"key":"2025121601510684000_13.10.e071766.17","doi-asserted-by":"publisher","DOI":"10.1002\/mds.26307"},{"key":"2025121601510684000_13.10.e071766.18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0028032","article-title":"Increased intestinal permeability correlates with sigmoid mucosa alpha-synuclein staining and endotoxin exposure markers in early parkinson's disease","volume":"6","author":"Forsyth","year":"2011","journal-title":"PLoS One"},{"key":"2025121601510684000_13.10.e071766.19","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.neubiorev.2020.02.003","article-title":"Gut microbiota differences between healthy older adults and individuals with parkinson's disease: a systematic review","volume":"112","author":"Nuzum","year":"2020","journal-title":"Neurosci Biobehav Rev"},{"key":"2025121601510684000_13.10.e071766.20","doi-asserted-by":"publisher","DOI":"10.1002\/mds.26069"},{"key":"2025121601510684000_13.10.e071766.21","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-08294-y"},{"key":"2025121601510684000_13.10.e071766.22","doi-asserted-by":"crossref","unstructured":"Maini Rekdal V , Bess EN , Bisanz JE , et al . Discovery and inhibition of an interspecies gut bacterial pathway for levodopa metabolism. Science 2019;364. doi:10.1126\/science.aau6323","DOI":"10.1126\/science.aau6323"},{"key":"2025121601510684000_13.10.e071766.23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0081330","article-title":"Microbiota dynamics in patients treated with fecal microbiota transplantation for recurrent clostridium difficile infection","volume":"8","author":"Song","year":"2013","journal-title":"PLoS ONE"},{"key":"2025121601510684000_13.10.e071766.24","doi-asserted-by":"publisher","DOI":"10.1152\/ajpgi.00282.2013"},{"key":"2025121601510684000_13.10.e071766.25","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00893-14","article-title":"Recovery of the gut microbiome following fecal microbiota transplantation","volume":"5","author":"Seekatz","year":"2014","journal-title":"mBio"},{"key":"2025121601510684000_13.10.e071766.26","doi-asserted-by":"crossref","first-page":"100642","DOI":"10.1016\/j.eclinm.2020.100642","article-title":"Faecal microbiota transplantation for recurrent clostridioides difficile infection: an updated systematic review and meta-analysis","volume":"29-30","author":"Baunwall","year":"2020","journal-title":"EClinicalMedicine"},{"key":"2025121601510684000_13.10.e071766.27","first-page":"e1","article-title":"Fecal microbiota transplantation for severe or fulminant clostridioides difficile infection","volume":"5","author":"Song","year":"2022","journal-title":"Systematic Review and Meta-Analysis J Can Assoc Gastroenterol"},{"key":"2025121601510684000_13.10.e071766.28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhin.2015.10.024"},{"key":"2025121601510684000_13.10.e071766.29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0161174","article-title":"Systematic review: adverse events of fecal microbiota transplantation","volume":"11","author":"Wang","year":"2016","journal-title":"PLoS One"},{"key":"2025121601510684000_13.10.e071766.30","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1177\/2050640620957765","article-title":"Faecal microbiota transplantation for clostridioides difficile infection: four years' experience of the Netherlands donor feces bank","volume":"8","author":"Terveer","year":"2020","journal-title":"United European Gastroenterol J"},{"key":"2025121601510684000_13.10.e071766.31","doi-asserted-by":"publisher","DOI":"10.1111\/apt.14201"},{"key":"2025121601510684000_13.10.e071766.32","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.cmi.2021.09.038","article-title":"European society of clinical microbiology and infectious diseases: 2021 update on the treatment guidance document for clostridioides difficile infection in adults","volume":"27","author":"van Prehn","year":"2021","journal-title":"Clin Microbiol Infect"},{"key":"2025121601510684000_13.10.e071766.33","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciab549"},{"key":"2025121601510684000_13.10.e071766.34","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2020.00098","article-title":"Fecal microbiota transplantation in neurological disorders","volume":"10","author":"Vendrik","year":"2020","journal-title":"Front Cell Infect Microbiol"},{"key":"2025121601510684000_13.10.e071766.35","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2016.11.018"},{"key":"2025121601510684000_13.10.e071766.36","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbi.2018.02.005"},{"key":"2025121601510684000_13.10.e071766.37","doi-asserted-by":"publisher","DOI":"10.1007\/s13311-019-00719-2"},{"key":"2025121601510684000_13.10.e071766.38","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000016163","article-title":"Fecal microbiota transplantation to treat parkinson's disease with constipation: a case report","volume":"98","author":"Huang","year":"2019","journal-title":"Medicine"},{"key":"2025121601510684000_13.10.e071766.39","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000022035","article-title":"Fecal microbiota transplantation therapy for parkinson's disease: a preliminary study","volume":"99","author":"Xue","year":"2020","journal-title":"Medicine (Baltimore)"},{"key":"2025121601510684000_13.10.e071766.40","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2021.106791"},{"key":"2025121601510684000_13.10.e071766.41","doi-asserted-by":"publisher","DOI":"10.1186\/s12934-021-01589-0"},{"key":"2025121601510684000_13.10.e071766.42","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2023.1104759","article-title":"Fecal Microbiota transplantation in parkinson\u2019s disease-a randomized repeat-dose, placebo-controlled clinical pilot study","volume":"14","author":"DuPont","year":"2023","journal-title":"Front Neurol"},{"key":"2025121601510684000_13.10.e071766.43","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2017.05.015"},{"key":"2025121601510684000_13.10.e071766.44","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.9227.1","article-title":"NG-tax, a highly accurate and validated pipeline for analysis of 16S rRNA Amplicons from complex biomes","volume":"5","author":"Ramiro-Garcia","year":"2016","journal-title":"F1000Res"},{"key":"2025121601510684000_13.10.e071766.45","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-019-0209-9"},{"key":"2025121601510684000_13.10.e071766.46","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkt1209"},{"key":"2025121601510684000_13.10.e071766.47","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1038\/ismej.2017.119","article-title":"Exact sequence variants should replace operational taxonomic units in marker-gene data analysis","volume":"11","author":"Callahan","year":"2017","journal-title":"ISME J"},{"key":"2025121601510684000_13.10.e071766.48","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/apt.16148","article-title":"Systematic review: the global incidence of faecal microbiota transplantation-related adverse events from 2000 to 2020","volume":"53","author":"Marcella","year":"2021","journal-title":"Aliment Pharmacol Ther"},{"key":"2025121601510684000_13.10.e071766.49","doi-asserted-by":"publisher","DOI":"10.7326\/M14-2693"},{"key":"2025121601510684000_13.10.e071766.50","doi-asserted-by":"crossref","DOI":"10.1186\/s12866-019-1689-y","article-title":"Long-term impact of fecal transplantation in healthy volunteers","volume":"19","author":"Goloshchapov","year":"2019","journal-title":"BMC Microbiol"},{"key":"2025121601510684000_13.10.e071766.51","doi-asserted-by":"publisher","DOI":"10.1097\/mcg.0000000000001281"},{"key":"2025121601510684000_13.10.e071766.52","doi-asserted-by":"publisher","DOI":"10.1177\/2050640616678099"},{"key":"2025121601510684000_13.10.e071766.53","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.281053"},{"key":"2025121601510684000_13.10.e071766.54","first-page":"13","article-title":"Medical research involving human subjects act","volume":"No. 152","year":"1999","journal-title":"Bull Med Ethics"},{"key":"2025121601510684000_13.10.e071766.55","doi-asserted-by":"publisher","DOI":"10.1111\/apt.13144"},{"key":"2025121601510684000_13.10.e071766.56","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1002\/mdc3.13621","article-title":"Targeting the gut-brain axis with fecal Microbiota transplantation: considerations on a potential novel treatment for parkinson's disease","volume":"10","author":"Contarino","year":"2023","journal-title":"Mov Disord Clin Pract"},{"key":"2025121601510684000_13.10.e071766.57","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.55.3.181"},{"key":"2025121601510684000_13.10.e071766.58","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.17.5.427"},{"key":"2025121601510684000_13.10.e071766.59","doi-asserted-by":"publisher","DOI":"10.1097\/MIB.0000000000001228"},{"key":"2025121601510684000_13.10.e071766.60","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2016.95"},{"key":"2025121601510684000_13.10.e071766.61","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-012-6624-1"},{"key":"2025121601510684000_13.10.e071766.62","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2011.12.011"},{"key":"2025121601510684000_13.10.e071766.63","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.2005.53221.x"},{"key":"2025121601510684000_13.10.e071766.64","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.parkreldis.2016.02.016","article-title":"Evaluation of severity of predominantly non-dopaminergic symptoms in parkinson's disease: the SENS-PD scale","volume":"25","author":"van der Heeden","year":"2016","journal-title":"Parkinsonism Relat Disord"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2023-071766","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T09:51:18Z","timestamp":1765878678000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2023-071766"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":64,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2023,10,5]]},"published-print":{"date-parts":[[2023,10]]}},"alternative-id":["10.1136\/bmjopen-2023-071766"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2023-071766","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10]]}}}